Price of 40-year-old cancer drug hiked 1,400% by new owners – CBS News
NextSource CEO Robert DiCrisci, told the Journal that the company sets its prices based on the costs it incurred in developing the medication and the benefits it provides patients. Like other drugmakers, the company provides discounts and financial assistance to those who can’t afford its cost.
Ab zu der Höhle der Löwen/Dragon’s Den!
[Update 27-Dez-2017|23:16]
Und jetzt funktioniert auch der Link.
Hopkins Blog 